Your browser doesn't support javascript.
loading
Mechanism for Covalent Binding of MLN3126, an Oral Chemokine C-C Motif Receptor 9 Antagonist, to Serum Albumins.
Narita, Naohiro; Morohashi, Akio; Tohyama, Kimio; Takeuchi, Toshiyuki; Tagawa, Yoshihiko; Kondo, Takahiro; Asahi, Satoru.
Afiliação
  • Narita N; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.) naohiro.narita@takeda.com
  • Morohashi A; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.).
  • Tohyama K; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.).
  • Takeuchi T; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.).
  • Tagawa Y; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.).
  • Kondo T; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.).
  • Asahi S; Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan (N.N., A.M., K.T., T.T., Y.T., S.A.); and Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan (T.K.).
Drug Metab Dispos ; 46(3): 204-213, 2018 03.
Article em En | MEDLINE | ID: mdl-29269409
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Albumina Sérica / Receptores CCR Tipo de estudo: Qualitative_research Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Albumina Sérica / Receptores CCR Tipo de estudo: Qualitative_research Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article